NCT05825014

Brief Summary

This study aims to develop predictive models for patients with a diagnosis of COPD at discharge of an index admission on these outcomes using machine learning: Primary outcome: Early admission Secondary outcomes:

  1. 1.Frequent readmission
  2. 2.Composite outcome (Early + Frequent readmissions)
  3. 3.Mortality
  4. 4.Longstayers

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100,000

participants targeted

Target at P75+ for all trials

Timeline
21mo left

Started Aug 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Aug 2023Apr 2028

First Submitted

Initial submission to the registry

April 11, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 24, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

August 29, 2023

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2028

Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

3.7 years

First QC Date

April 11, 2023

Last Update Submit

March 17, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Early Readmission

    Patients were readmitted to hospital with the primary diagnosis of AECOPD\* within 30 days since the discharge date of the index admission

    30 days

Secondary Outcomes (3)

  • Frequent Admitters

    365 days

  • 1-Year Mortality

    365 days

  • Longstayers

    365 days

Interventions

No intervention

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients are discharged from 2016 -2022 from hospital for acute exacerbation of COPD

You may qualify if:

  • ≥40 years
  • Patients are discharged from 2016 -2022
  • Discharge Diagnosis: Using the Discharge Diagnosis ICD Codes found in the Primary Diagnosis to determine if a patient has COPD
  • Validated against Spirometry results (for patient with a spirometry reading):
  • Spirometry reading taken from anytime point before. Patient should have Post FEV1/FVC ratio of \< 0.7 in any one of the spirometry readings. If Post FEV1/FVC is not available, we will check if patients have a Pre FEV1/FVC value, and will also include patients with Pre FEV1/FVC ratio of \< 0.7 in any one of the spirometry readings.

You may not qualify if:

  • Admission diagnosis due to causes other than COPD

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Chinese University of Hong Kong

Hong Kong, New Territories, Hong Kong

RECRUITING

Study Officials

  • David Hui, MD

    Chinese University of Hong Kong

    STUDY DIRECTOR

Central Study Contacts

Fanny Ko, MD

CONTACT

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Honorary Clinical Associate Professor

Study Record Dates

First Submitted

April 11, 2023

First Posted

April 24, 2023

Study Start

August 29, 2023

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

April 30, 2028

Last Updated

March 18, 2026

Record last verified: 2026-03

Locations